Results 31 to 40 of about 26,786 (248)
Background: Current guidelines for antithrombotic prophylaxis during transcatheter aortic valve replacement (TAVR) are empirically extrapolated from the percutaneous coronary intervention (PCI) setting despite patient and procedural differences ...
Christopher Anstey +13 more
core +1 more source
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? [PDF]
Transcatheter mitral interventions has been developed to address an unmet clinical need and may be an alternative therapeutic option to surgery with the intent to provide symptomatic and prognostic benefit.
Maisano, Francesco +25 more
core +2 more sources
Multimodality imaging for transcatheter tricuspid valve repair and replacement
Transcatheter tricuspid intervention is a rapidly evolving field with multiple classes of therapeutic devices currently in development. Procedural success in tricuspid intervention is predicated on appropriate device selection for patient specific ...
Stephen Tomlinson +4 more
doaj +1 more source
Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta-analysis [PDF]
BackgroundRecent recommendations suggest that in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation and coexistent significant coronary artery disease, the latter should be treated before the index procedure; however,
Mamas
core +1 more source
Transcatheter techniques for the treatment of tricuspid regurgitation (TR) are being more frequently used and several new devices are in development.
Nina C. Wunderlich +6 more
doaj +1 more source
Open issues and next challenges in transcatheter mitral valve intervention [PDF]
New transcatheter techniques have been recently developed to treat mitral regurgitation with less invasive approaches in high risk and elderly patients. This research is concentrated on the definition of the optimal candidate or optimal approach for some
Taramasso, Maurizio
core +1 more source
Tricuspid Regurgitation: A Review of Current Interventional Management
Tricuspid regurgitation is a common yet clinically complex problem, traditionally managed with diuretic therapy with no observable mortality benefit. Older studies on surgical intervention observed poor outcomes; however, this clinical reasoning predates
Maxwell Ambrosino +6 more
doaj +1 more source
COVID-19 infection has myriad manifestations from self-limiting illness to stormy multi-organ failure. A 28-year-old woman negative for COVID reverse transcription–polymerase chain reaction underwent an uneventful elective device closure of atrial septal
Anil Kumar Singhi +5 more
doaj +1 more source
Transcatheter closure of patent ductus arteriosus (PDA) is now the standard of care with some exceptions. Best treatment for peripheral pulmonary artery (PA) stenosis in small children is still debatable.
Mahua Roy +4 more
doaj +1 more source
Background: Mitral transcatheter edge-to-edge repair (M-TEER) is a treatment option for patients with severe mitral regurgitation (MR) at a high surgical risk.
Jason H. Rogers, MD +14 more
doaj +1 more source

